Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Treatment of Borderline Personality Disorder With rTMS

NCT: NCT07197502 · RECRUITING

NCT IDNCT07197502
StatusRECRUITING
Start Date2025-03-01
Completion2027-12-31
SponsorUniversity of California, Los Angeles (OTHER)
First posted
Last updated

Brief Summary

This project studies the effectiveness of brain stimulation on borderline personality disorder (BPD) symptoms. This study is blinded, randomized and will enroll up to 30 participants. Participant will be consented for the study remotely via a secure internet platform called Zoom. Participants will undergo up to 2 MRI scans, 2 brain wave recording sessions and up to 30 brain stimulation treatments, and complete symptom assessments and cognitive behavioral tasks on a computer. Participation requires minimum of 17 in person visits over the course of 2.5 months. Participants are randomly assigned active or sham brain stimulation. Participants who received sham brain stimulation have the option to receive additional 15 active brain stimulation session.

Frequently Asked Questions

What is Treatment of Borderline Personality Disorder With rTMS?

Treatment of Borderline Personality Disorder With rTMS is a clinical trial registered under NCT07197502. Current status: RECRUITING.

What is the status of NCT07197502?

The current status of NCT07197502 (Treatment of Borderline Personality Disorder With rTMS) is: RECRUITING.

When did Treatment of Borderline Personality Disorder With rTMS start?

Treatment of Borderline Personality Disorder With rTMS started on 2025-03-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.